Clinical Study
Efficacy of Diltiazem for the Control of Blood Pressure in Puerperal Patients with Severe Preeclampsia: A Randomized, Single-Blind, Controlled Trial
Table 1
Clinical and biochemical features of the treatments at baseline.
| | Variable | Diltiazem (n = 21) | Nifedipine (n = 21) | value |
| | Pregnancy and maternity characteristics | | Maternal age (years) | 21.6 (6.8) | 23.2 (6.2) | 0.43 | | Gestational age (weeks) | 36.4 (3.5) | 36.4 (2.1) | 0.99 | | Childbirth (caesarean section) | 20/21 (95.2%) | 21/21 (100%) | 1.00 | | Pregnancy (primiparous) | 16 (76.19%) | 13 (61.90%) | 0.51 | | Liver and kidney functions | | AST (U/L) | 29.90 (10.36) | 29.38 (7.34) | 0.85 | | ALT (U/L) | 20.90 (11.89) | 30.47 (46.33) | 0.36 | | Serum creatinine (mg/dL) | 0.866 (0.229) | 0.843 (0.159) | 0.70 | | Baseline levels of arterial blood pressure variables | | Systolic blood pressure (mmHg) | 156.2 (13.6) | 158.3 (14.0) | 0.63 | | Diastolic blood pressure (mmHg) | 112.6 (5.5) | 111.2 (7.6) | 0.49 | | Mean blood pressure (mmHg) | 127.1 (6.9) | 126.9 (7.8) | 0.91 | | Heart rate (beats/min) | 103.4 (14.9) | 96.4 (14.6) | 0.13 |
|
|
AST: aspartate amino transferase; ALT: alanine amino transferase. Significant values are bolded. |
